Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R R Bowsher

Showing results (41-50 of 61) with videos related to

Pageof 7
Sort By:
The American Journal of Physiology|July 1, 1996
Effects of circulating IGF-I on glucose and amino acid kinetics in the ovine fetusE A Liechty, D W Boyle, H Moorehead, et al.
Journal of Pharmaceutical Sciences|October 9, 1999
Pharmacokinetic and glucodynamic comparisons of recombinant and animal-source glucagon after IV, IM, and SC injection in healthy volunteersC J Graf, J R Woodworth, M E Seger, et al.
Diabetes Care|July 1, 1992
Fluctuations in plasma proinsulin in an insulinoma. Implications for screening testE Ipp, R H Tarris, S M Griffiths, et al.
Endocrinology|February 1, 1991
Measurement of insulin-like growth factor-II in physiological fluids and tissues. I. An improved extraction procedure and radioimmunoassay for human and rat fluidsR R Bowsher, W H Lee, J M Apathy, et al.
Clinical Chemistry|October 1, 1992
Sensitive, specific radioimmunoassay for quantifying pergolide in plasmaR R Bowsher, J M Apathy, J A Compton, et al.
Biotechnology and Applied Biochemistry|December 1, 1987
Chemical, physical, and biological characterization of a dimeric form of biosynthetic human growth hormoneG W Becker, R R Bowsher, W C Mackellar, et al.
The Journal of Clinical Endocrinology and Metabolism|December 1, 1994
Disproportionately increased proinsulin levels are associated with the insulin resistance syndromeS M Haffner, L Mykkänen, R A Valdez, et al.
Diabetes Care|May 1, 1994
Comparative pharmacokinetics and glucodynamics of two human insulin mixtures. 70/30 and 50/50 insulin mixturesJ R Woodworth, D C Howey, R R Bowsher, et al.
Clinical Pharmacology and Therapeutics|October 1, 1995
[Lys(B28), Pro(B29)]-human insulin: effect of injection time on postprandial glycemiaD C Howey, R R Bowsher, R L Brunelle, et al.
Diabetes Care|May 1, 1992
Biosynthetic human proinsulin. Review of chemistry, in vitro and in vivo receptor binding, animal and human pharmacology studies, and clinical trial experienceJ A Galloway, S A Hooper, C T Spradlin, et al.
Pageof 7

Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
The American Journal of Physiology|July 1, 1996
Effects of circulating IGF-I on glucose and amino acid kinetics in the ovine fetusE A Liechty, D W Boyle, H Moorehead, et al.
Journal of Pharmaceutical Sciences|October 9, 1999
Pharmacokinetic and glucodynamic comparisons of recombinant and animal-source glucagon after IV, IM, and SC injection in healthy volunteersC J Graf, J R Woodworth, M E Seger, et al.
Diabetes Care|July 1, 1992
Fluctuations in plasma proinsulin in an insulinoma. Implications for screening testE Ipp, R H Tarris, S M Griffiths, et al.
Endocrinology|February 1, 1991
Measurement of insulin-like growth factor-II in physiological fluids and tissues. I. An improved extraction procedure and radioimmunoassay for human and rat fluidsR R Bowsher, W H Lee, J M Apathy, et al.
Clinical Chemistry|October 1, 1992
Sensitive, specific radioimmunoassay for quantifying pergolide in plasmaR R Bowsher, J M Apathy, J A Compton, et al.
Biotechnology and Applied Biochemistry|December 1, 1987
Chemical, physical, and biological characterization of a dimeric form of biosynthetic human growth hormoneG W Becker, R R Bowsher, W C Mackellar, et al.
The Journal of Clinical Endocrinology and Metabolism|December 1, 1994
Disproportionately increased proinsulin levels are associated with the insulin resistance syndromeS M Haffner, L Mykkänen, R A Valdez, et al.
Diabetes Care|May 1, 1994
Comparative pharmacokinetics and glucodynamics of two human insulin mixtures. 70/30 and 50/50 insulin mixturesJ R Woodworth, D C Howey, R R Bowsher, et al.
Clinical Pharmacology and Therapeutics|October 1, 1995
[Lys(B28), Pro(B29)]-human insulin: effect of injection time on postprandial glycemiaD C Howey, R R Bowsher, R L Brunelle, et al.
Diabetes Care|May 1, 1992
Biosynthetic human proinsulin. Review of chemistry, in vitro and in vivo receptor binding, animal and human pharmacology studies, and clinical trial experienceJ A Galloway, S A Hooper, C T Spradlin, et al.
Pageof 7